iShares Neuroscience and Healthcare ETF
IBRN
5 hedge funds and large institutions have $1.42M invested in iShares Neuroscience and Healthcare ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 5 → 5 (0)
20.7% less ownership
Funds ownership: 45.13% → 24.43% (-21%)
36% less capital invested
Capital invested by funds: $2.23M → $1.42M (-$808K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$4.63K |
| 2 |
AssetMark Inc
Concord,
California
|
+$3.51K |
| 3 |
IFWM
Institute for Wealth Management
Denver,
Colorado
|
+$3.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.09M |
| 2 |
SPIA
Steward Partners Investment Advisory
New York
|
-$7.08K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$98 |
IBRN Hedge Fund Activity: Q2 2026 in Review
5 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in iShares Neuroscience and Healthcare ETF (IBRN) for Q2 2026, worth a combined $1.42M — down 36% from $2.23M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IBRN positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $4.63K. The largest seller was BlackRock, cutting an estimated $1.09M.
- 5 institutional investors held iShares Neuroscience and Healthcare ETF (IBRN) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $1.42M of iShares Neuroscience and Healthcare ETF stock for Q2 2026, down 36% quarter-over-quarter.
- 2 funds opened new iShares Neuroscience and Healthcare ETF positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest iShares Neuroscience and Healthcare ETF buyer in Q2 2026 was UBS Group, an estimated $4.63K added.
- The largest iShares Neuroscience and Healthcare ETF seller in Q2 2026 was BlackRock, an estimated $1.09M sold.
Based on aggregated 13F filings for Q2 2026.